135 related articles for article (PubMed ID: 12053067)
21. Plasma adiponectin concentration before and after successful kidney transplantation.
Chudek J; Adamczak M; Karkoszka H; Budziński G; Ignacy W; Funahashi T; Matsuzawa Y; Cierpka L; Kokot F; Wiecek A
Transplant Proc; 2003 Sep; 35(6):2186-9. PubMed ID: 14529883
[TBL] [Abstract][Full Text] [Related]
22. Oxalic Acid as a uremic toxin.
Mydlík M; Derzsiová K
J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
[TBL] [Abstract][Full Text] [Related]
23. Investigation on the early events of apoptosis in senescent erythrocytes with special emphasis on intracellular free calcium and loss of phospholipid asymmetry in chronic renal failure.
Sakthivel R; Farooq SM; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2007 Jul; 382(1-2):1-7. PubMed ID: 17449019
[TBL] [Abstract][Full Text] [Related]
24. [The effect of hemodialysis on some parameters of the antioxidant system in the blood of patients with chronic renal failure].
Olszewska M
Ann Acad Med Stetin; 2004; 50(1):41-52. PubMed ID: 16871743
[TBL] [Abstract][Full Text] [Related]
25. Geographic factors and plasma selenium in uremia and dialysis.
Bonomini M; Forster S; Manfrini V; De Risio F; Steiner M; Vidovich MI; Klinkmann H; Ivanovich P; Albertazzi A
Nephron; 1996; 72(2):197-204. PubMed ID: 8684527
[TBL] [Abstract][Full Text] [Related]
26. Hyperglucagonemia in uremia: reversal by renal transplantation.
Bilbrey GL; Faloona GR; White MG; Atkins C; Hull AR; Knochel JP
Ann Intern Med; 1975 Apr; 82(4):525-8. PubMed ID: 1091189
[TBL] [Abstract][Full Text] [Related]
27. Lipid peroxidation and antioxidant enzymes in children with chronic renal failure.
Zwolińska D; Grzeszczak W; Kiliś-Pstrusińska K; Szprynger K; Szczepańska M
Pediatr Nephrol; 2004 Aug; 19(8):888-92. PubMed ID: 15179570
[TBL] [Abstract][Full Text] [Related]
28. Ghrelin and other appetite-regulating hormones in paediatric patients with chronic renal failure during dialysis and following kidney transplantation.
Arbeiter AK; Büscher R; Petersenn S; Hauffa BP; Mann K; Hoyer PF
Nephrol Dial Transplant; 2009 Feb; 24(2):643-6. PubMed ID: 18809976
[TBL] [Abstract][Full Text] [Related]
29. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure.
Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H
Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995
[TBL] [Abstract][Full Text] [Related]
30. 4-pyridone-3-carboxamide ribonucleoside triphosphate accumulating in erythrocytes in end stage renal failure originates from tryptophan metabolism.
Laurence A; Edbury SM; Marinaki AM; Smolenski RT; Goldsmith DJ; Simmonds HA; Carrey EA
Clin Exp Med; 2007 Dec; 7(4):135-41. PubMed ID: 18188525
[TBL] [Abstract][Full Text] [Related]
31. Erythrocyte nucleotides and blood hypoxanthine in patients with uremia evaluated immediately and 24 hours after hemodialysis.
Bułło B; Marlewski M; Smoleński RT; Rutkowski B; Swierczyński J; Manitius J
Ren Fail; 1996 Mar; 18(2):247-52. PubMed ID: 8723362
[TBL] [Abstract][Full Text] [Related]
32. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
33. Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: positive correlation with degree of renal failure.
Carrey EA; Smolenski RT; Edbury SM; Laurence A; Marinaki AM; Duley JA; Zhu L; Goldsmith DJ; Simmonds HA
Clin Chim Acta; 2003 Sep; 335(1-2):117-29. PubMed ID: 12927693
[TBL] [Abstract][Full Text] [Related]
34. Increased susceptibility to erythrocyte C5b-9 deposition and complement-mediated lysis in chronic renal failure.
Himmelfarb J; McMonagle E; Holbrook D; Hakim R
Kidney Int; 1999 Feb; 55(2):659-66. PubMed ID: 9987090
[TBL] [Abstract][Full Text] [Related]
35. A novel nucleotide found in human erythrocytes, 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate.
Slominska EM; Carrey EA; Foks H; Orlewska C; Wieczerzak E; Sowinski P; Yacoub MH; Marinaki AM; Simmonds HA; Smolenski RT
J Biol Chem; 2006 Oct; 281(43):32057-64. PubMed ID: 16920716
[TBL] [Abstract][Full Text] [Related]
36. Plasma levels of atrial natriuretic peptide in patients with chronic renal failure.
Hasegawa K; Matsushita Y; Inoue T; Morii H; Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1986 Oct; 63(4):819-22. PubMed ID: 2943754
[TBL] [Abstract][Full Text] [Related]
37. 4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?
Synesiou E; Fairbanks LD; Simmonds HA; Slominska EM; Smolenski RT; Carrey EA
Toxins (Basel); 2011 Jun; 3(6):520-37. PubMed ID: 22069723
[TBL] [Abstract][Full Text] [Related]
38. Accumulation of plasma N-methyl-2-pyridone-5-carboxamide in patients with chronic renal failure.
Slominska EM; Smolenski RT; Szolkiewicz M; Leaver N; Rutkowski B; Simmonds HA; Swierczynski J
Mol Cell Biochem; 2002 Feb; 231(1-2):83-8. PubMed ID: 11952169
[TBL] [Abstract][Full Text] [Related]
39. Rapid correction of red-cell nucleotide abnormalities following successful renal transplantation.
Rejman AS; Mansell MA; Grimes AJ; Joekes AM
Br J Haematol; 1985 Nov; 61(3):433-43. PubMed ID: 3904813
[TBL] [Abstract][Full Text] [Related]
40. Magnesium metabolism in erythrocytes of patients with chronic renal failure and after renal transplantation.
Vormann J; Günther T; Perras B; Rob PM
Eur J Clin Chem Clin Biochem; 1994 Dec; 32(12):901-4. PubMed ID: 7696437
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
